Long-term survival in ursodeoxycholic acid treated patients with primary biliary cirrhosis

被引：0
|
作者：
Poupon, RE
Bonnand, AM
Chretien, Y
Poupon, R
机构：
[1] INSERM,U21,VILLEJUIF,FRANCE
[2] HOP ST ANTOINE,F-75571 PARIS,FRANCE
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：936 / 936
页数：1
相关论文
共 50 条
  • [31] LONG-TERM SAFETY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS
    Peters, Y.
    Hooshmand-rad, R.
    Pencek, R.
    Owens-grillo, J.
    Marmon, T.
    Macconell, L.
    Picaro, L. A.
    Adorini, L.
    Shapiro, D.
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 : E117 - E118
  • [32] The impact of ursodeoxycholic acid (UDCA) therapy with or without liver transplantation (OLT) on long-term survival in primary biliary cirrhosis.
    Corpechot, C
    Carrat, F
    Bahr, A
    Poupon, RE
    Poupon, R
    [J]. HEPATOLOGY, 2003, 38 (04) : 519A - 519A
  • [33] PROGNOSIS OF PRIMARY BILIARY CIRRHOSIS WITH FEATURES OF AUTOIMMUNE HEPATITIS OVERLAP SYNDROME. ROLE OF URSODEOXYCHOLIC ACID IN LONG-TERM SURVIVAL
    Pares, A.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S391 - S391
  • [34] Anticholestatic Effects of Bezafibrate in Patients with Primary Biliary Cirrhosis Treated with Ursodeoxycholic Acid
    Honda, Akira
    Ikegami, Tadashi
    Nakamuta, Makoto
    Miyazaki, Teruo
    Iwamoto, Junichi
    Hirayama, Takeshi
    Saito, Yoshifumi
    Takikawa, Hajime
    Imawari, Michio
    Matsuzaki, Yasushi
    [J]. HEPATOLOGY, 2013, 57 (05) : 1931 - 1941
  • [35] LONG-TERM THERAPY WITH BEZAFIBRATE AND URSODEOXYCHOLIC ACID IS INSUFFICIENT FOR PREVENTING DISEASE PROGRESSION IN PATIENTS WITH ADVANCED PRIMARY BILIARY CIRRHOSIS
    Reig, A.
    Sese, P.
    Pares, A.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S806 - S806
  • [36] Biochemical Response to Ursodeoxycholic Acid Predicts Long-Term Outcome in Japanese Patients With Primary Biliary Cirrhosis: A Validation Study
    Azemoto, Nobuaki
    Kumagi, Teru
    Abe, Masanori
    Konishi, Ichiro
    Matsuura, Bunzo
    Hiasa, Yoichi
    Onji, Morikazu
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S918 - S918
  • [37] LONG TERM THERAPY WITH FENOFIBRATE AND URSODEOXYCHOLIC ACID DOES NOT IMPROVE PROJECTED SURVIVAL IN PRIMARY BILIARY CHOLANGITIS (CIRRHOSIS)
    Hegade, V. S.
    Khanna, A.
    Wong, L. L.
    Dyson, J. K.
    Jones, D.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S651 - S651
  • [38] LONG-TERM SURVIVAL OF ASYMPTOMATIC AND SYMPTOMATIC PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS
    ROLL, J
    BOYER, J
    KLATSKIN, G
    [J]. GASTROENTEROLOGY, 1980, 79 (05) : 1050 - 1050
  • [39] Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years
    Chan, CW
    Gunsar, F
    Feudjo, M
    Rigamonti, C
    Vlachogiannakos, J
    Carpenter, JR
    Burroughs, AK
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (03) : 217 - 226
  • [40] Disappearance of antimitochondrial antibody in primary biliary cirrhosis during long-term ursodeoxycholic acid treatment.
    Yamazaki, K
    Nakamura, A
    Abe, S
    Abe, K
    Suzuki, K
    Sato, S
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A1364 - A1364
12345